Prolyl hydroxylase domain 3 influences the radiotherapy efficacy of pancreatic cancer cells by targeting hypoxia-inducible factor-1α

Prolyl hydroxylase domain 3 influences the radiotherapy efficacy of pancreatic cancer cells by targeting hypoxia-inducible factor-1α

Li-rui Tang,1,* Jun-xin Wu,1,* Shao-li Cai,2 Yun-xia Huang,1 Xue-qing Zhang,1 Wan-kai Fu,1 Qing-yang Zhuang,1 Jin-luan Li1 1Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China; 2Key Laboratories of Innate Immune Biology of Fujian Provin...

Full description

Bibliographic Details
Main Authors: Tang L, Wu J, Cai S, Huang Y, Zhang X, Fu W, Zhuang Q, Li J
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:OncoTargets and Therapy
Subjects:
pancreatic cancer
PHD3
radiotherapy efficacy
HIF-1α
p-EGFR
Online Access:https://www.dovepress.com/prolyl-hydroxylase-domain-3-influences-the-radiotherapy-efficacy-of-pa-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/prolyl-hydroxylase-domain-3-influences-the-radiotherapy-efficacy-of-pa-peer-reviewed-article-OTT

Similar Items